Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • News

    New study of diabetes drug for COVID-19 raises eyebrows

    May 1, 2020

    Some question the safety of AstraZeneca’s just-launched DARE-19 study testing whether dapagliflozin will reduce adverse outcomes of COVID-19.

  • News

    Yale’s COVID-19 inpatient protocol: Hydroxychloroquine plus/minus tocilizumab

    April 30, 2020

    Yale cardiologist offers lessons from “the haze of battle” on fighting COVID-19 with little evidence.

  • 1
    News

    Survey: Hydroxychloroquine use fairly common in COVID-19

    April 29, 2020

    Testing and preparedness have increased, but a return to normal life could take another 6 months.

  • News

    SGLT2 inhibitor ertugliflozin shows no CV death or renal benefit

    April 29, 2020

    Merck reports topline results from ertugliflozin’s FDA-mandated cardiovascular outcomes trial.

  • News

    Consensus recommendations on AMI management during COVID-19

    April 28, 2020

    The ACC, ACEP, and SCAI recommend a systematic approach for the care of patients with an acute myocardial infarction during the COVID-19 pandemic.

  • News

    Seniors with COVID-19 show unusual symptoms, doctors say

    April 27, 2020

    The age group most at risk of severe complications may not have fever, insistent cough, or shortness of breath.

  • News

    COVID-19 linked to large vessel stroke in young adults

    April 27, 2020

    The virus appears to cause disease through a process of blood clotting, according to an expert.

  • 1
    News

    FDA reiterates hydroxychloroquine limitations for COVID-19

    April 24, 2020

    An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial.

  • 1
    News

    COVID-19: What are the major cardiovascular issues?

    April 24, 2020

    COVID myocarditis can mimic acute MI or stress cardiomyopathy and will present diagnostic and therapeutic challenges.

  • News

    Angiotensin drugs and COVID-19: More reassuring data

    April 24, 2020

    Data from one Wuhan hospital show no difference in COVID-19 severity or mortality in patients with hypertension taking ACE inhibitors or ARBs. Other reassuring studies are also emerging.

Previous1 … 33 34 35 36 37 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences